Darifenacin
NDC 16571-767, Darifenacin, tablet, film coated, extended release, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-767
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206743
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-767 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DARIFENACIN HYDROBROMIDE7.5 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-767-03 | 16571076703 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16571-767-03) |
| 16571-767-09 | 16571076709 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16571-767-09) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e2aa9544-0136-463d-a73b-1a299534446aNADAC price for package 16571076703
GET /v1/drugs/nadac/16571076703NADAC price for package 16571076709
GET /v1/drugs/nadac/16571076709
Use it
Look up 16571-767 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-767 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-767. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.